Graham Cooke

Last updated
Graham Cooke
FRCP , FMedSci
Born
Hemel Hempstead, Hertfordshire, England
NationalityBritish
Education Watford Boys Grammar School
Alma mater St John's College, Cambridge
Worcester College, Oxford
University of KwaZulu-Natal
Scientific career
Fields Infectious diseases
Institutions Imperial College London
Thesis Host genetic of susceptibility to tuberculosis (2003)

Professor Graham Cooke FRCP FMedSci is a clinician scientist and NIHR Professor of Infectious Diseases at the Wright-Fleming Institute of Imperial College London. [1] He is best known for his work on viral hepatitis, particularly hepatitis C. [2] [3]

Contents

Early life and education

Educated at Watford Grammar School for Boys, he studied natural sciences and medicine at University of Cambridge. Later he undertook his doctoral studies with Adrian V. S. Hill at the Wellcome Center for Human Genetics, studying human genetic variation and its role in susceptibility to tuberculosis. [4]

Research and career

After specialist training in London, Cooke was based at the Africa Centre for Health and Population Studies, Mtubatuba (now AHRI) before moving to Imperial College. [5] His work has focussed on HIV, tuberculosis and viral hepatitis. [1] In 2016 he led publication of global estimates of viral hepatitis disease burden and has had a prominent role in efforts to raise the profile of viral hepatitis globally, leading the commission on viral hepatitis elimination in 2019. [1] He has run randomised trials in the UK and Vietnam contributing insights into host-virus interactions and treatment outcomes. [6]

COVID-19

During the COVID-19 pandemic, Cooke was an investigator on the REACT (Real-time Assessment of Community Transmission) programme, the largest study of consented individuals during the pandemic. [7] [8] The programme made important contributions to government policy and informed decisions on relaxation of national restrictions and vaccine delivery. [9]

With Chris Toumazou, he led the development of the COVIDnudge diagnostic, [10] implemented in the NHS in 2020. [11]

Other roles

He has advocated for access to affordable medicines. [12] He became a member of the WHO committee for Selection and Use of Essential Medicines in 2015 and chairman in 2019. [1] [13] In 2021, he was appointed non-executive director and Deputy Chair of the Medicines and Healthcare products Regulatory Agency Board (MHRA). [14]

Honours

He is a Fellow of the Royal College of Physicians (2012), [15] National Institute for Health and Care Research (NIHR) Research Professor (2017), Fellow of the Academy of Medical Sciences (2023). [16]

Related Research Articles

<span class="mw-page-title-main">Lamivudine</span> Chemical compound

Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS. It is also used to treat chronic hepatitis B when other options are not possible. It is effective against both HIV-1 and HIV-2. It is typically used in combination with other antiretrovirals such as zidovudine, dolutegravir, and abacavir. Lamivudine may be included as part of post-exposure prevention in those who have been potentially exposed to HIV. Lamivudine is taken by mouth as a liquid or tablet.

<span class="mw-page-title-main">Chris Toumazou</span> British academic

Christofer "Chris" Toumazou, CEng is a British Cypriot electronic engineer. He is perhaps best known for inventing a fast and portable means of genome sequencing, following his 13-year-old son's diagnosis with end stage kidney failure through a rare genetic mutation.

The National Institute for Health and Care Research (NIHR) is the British government's major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.

<span class="mw-page-title-main">Prison healthcare</span> Medical treatment in prisons, jails, and other penal institutions

Prison healthcare is the medical specialty in which healthcare providers care for people in prisons and jails. Prison healthcare is a relatively new specialty that developed alongside the adaption of prisons into modern disciplinary institutions. Enclosed prison populations are particularly vulnerable to infectious diseases, including arthritis, asthma, hypertension, cervical cancer, hepatitis, tuberculosis, AIDS, and HIV, and mental health issues, such as Depression, mania, anxiety, and post-traumatic stress disorder. These conditions link prison healthcare to issues of public health, preventive healthcare, and hygiene. Prisoner dependency on provided healthcare raises unique problems in medical ethics.

<span class="mw-page-title-main">Alimuddin Zumla</span> British-Zambian physician

Sir Alimuddin Zumla,, FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2023, for the sixth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.

<span class="mw-page-title-main">Kevin Fenton</span> British epidemiologist

Professor Kevin Andrew Fenton, is a Public Health Physician and Infectious Disease Epidemiologist. He is the London Regional Director at Office for Health Improvement and Disparities, Regional Public Health Director at NHS London and the Statutory Health Advisor to the Mayor of London, Sadiq Khan. He is the current President of the United Kingdom Faculty of Public Health and holds Honourable Professorships with the University College London and London School of Hygiene and Tropical Medicine.

The Medicines Patent Pool (MPP) is a Unitaid-backed international organisation founded in July 2010, based in Geneva, Switzerland. Its public health driven business model aims to lower the prices of HIV, tuberculosis and hepatitis C medicines and facilitate the development of better-adapted HIV treatments through voluntary licensing and patent pooling. Its goal is to improve access to affordable and appropriate HIV, hepatitis C and tuberculosis medicines in low- and middle-income countries (LMIC). In May 2020, the MPP become an implementing partner of the WHO's Covid-19 Technology Access Pool (C-TAP).

Peter John Morland Openshaw, is a British clinician and scientist specialising in lung immunology, particularly defence against viral infections. He trained in lung diseases and undertook a PhD in immunology before establishing a laboratory at St Mary's Hospital Medical School. He created the academic department of Respiratory Medicine and the Centre for Respiratory Infection at Imperial College and was elected President of the British Society for Immunology in 2014.

Sharon Jayne Peacock is a British microbiologist who is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge. Peacock also sits on Cambridge University Council.

<span class="mw-page-title-main">Christina Pagel</span> British German mathematician

Christina Pagel is a German-British mathematician and professor of operational research at University College London (UCL) within UCL's Clinical Operational Research Unit (CORU), which applies operational research, data analysis and mathematical modelling to topics in healthcare. She was Director of UCL CORU from 2017 to 2022 and is currently Vice President of the UK Operational Research Society. She also co-leads, alongside Rebecca Shipley, UCL's CHIMERA research hub which analyses data from critically ill hospital patients.

Eleni Nastouli is a Greek clinical virologist who works at University College London Hospitals NHS Foundation Trust (UCLH) and Great Ormond Street Hospital. At UCLH, Nastouli leads the Advanced Pathogen Diagnostics Unit, where she develops technologies for genome sequencing as well as studying how viruses are transmitted around hospitals. During the COVID-19 pandemic Nastouli led an investigation into infection rates amongst healthcare workers.

Azeem Majeed is a Professor and Head of the Department of Primary Care & Public Health at Imperial College, London, as well as a general practitioner in South London and a consultant in public health. In the most recent UK University Research Excellence Framework results, Imperial College London was the highest ranked university in the UK for the quality of research in the “Public Health, Health Services and Primary Care” unit of assessment.

<span class="mw-page-title-main">Justin Stebbing</span> British oncology doctor and cancer researcher

Justin Stebbing is a British clinician-scientist specialising in oncology and cancer research. He is a professor of biomedical sciences at Anglia Ruskin University and practices with the private sector Phoenix Hospital Group in London.

Sonia Saxena FRCGP is a British physician who is a Professor of Primary care and Director of the Child Health Unit at the School of Public Health, Imperial College London. She is a Fellow of the Royal College of General Practitioners and a practises as a GP in Putney, London. She is known for her work in improving healthcare, and a focus on improving child health in the early years of life and reducing social inequalities.

Eleanor Barnes is a British physician at the John Radcliffe Hospital and a Professor of Hepatology and Experimental Medicine at the University of Oxford. She has studied hepatitis C and the development of the development of HCV vaccines. She is a Fellow of the Academy of Medical Sciences and serves as the lead for hepatology at the National Institute for Health Research (NIHR) Clinical Research Network.

Waljit Dhillo is an endocrinologist and a Professor of Endocrinology & Metabolism at the Imperial College London. He is the Director of Research at the Division of Medicine & Integrated Care at Imperial College Healthcare NHS Trust and the Dean of the National Institute for Health and Care Research (NIHR) Academy. His research focuses on how the endocrine system controls body weight and reproductive functions.

<span class="mw-page-title-main">Adeel A. Butt</span> Pakistani-American infectious diseases physician and professor

Adeel Ajwad Butt is a Pakistani–American infectious diseases physician, Professor of Medicine and Population Health Sciences at the Weill-Cornell Medical College He is also the founder president and CEO of Innovations in Healthcare Advocacy, Research and Training (I-HART).

Rifat Atun is a British physician and academic who, as of January 2024, serves as the Professor of Global Health Systems and Director of the Health System Innovation Lab at Harvard University. He is one of the most important figures in the contemporary study of comparative health systems and healthcare innovation and has made substantial contributions to health systems theory, health systems reform, and innovation in health systems.

Jonathan Jeffers is a mechanical engineer and Professor of Mechanical Engineering at Imperial College London. He was awarded a Research Professorship by the National Institute for Health and Care Research (NIHR), the first engineer to receive this award. His research focuses on improving surgical treatment of osteoarthritis.

<span class="mw-page-title-main">Anthony Gordon (scientist)</span> British medical professor

Anthony Gordon is a British clinician scientist and the Chair of Anaesthesia & Critical Care at Imperial College London and works as an intensive care consultant at Imperial College Healthcare NHS Trust.

References

  1. 1 2 3 4 "Home - Professor Graham Cooke". Imperial.ac.uk. Retrieved 5 March 2019.
  2. ↑ "Hepatitis C research pioneer wins prestigious award". Imperial.ac.uk. Retrieved 5 March 2019.
  3. ↑ "Hepatitis C elimination in people living with HIV in the UK is feasible by 2021, British HIV Association says". Infohep.org. Retrieved 5 March 2019.
  4. ↑ "Human genetics and susceptibility to tuberculosis" . Retrieved 20 March 2019.
  5. ↑ "Graham Cooke". Coalition for Global Hepatitis Elimination. Retrieved 2023-08-14.
  6. ↑ Cooke, Graham. "VIETNarms: a multi-arm trial of HCV treatment strategies in Vietnam". ISRCTN. doi: 10.1186/isrctn61522291 . Retrieved 2023-08-14.
  7. ↑ "Find out about REACT". Imperial College London. Retrieved 2023-08-14.
  8. ↑ "Largest COVID-19 testing study shows cases are rising across England". Imperial News. 2020-09-11. Retrieved 2023-08-14.
  9. ↑ "Real-time surveillance to improve situational awareness of COVID-19: the REACT study". results2021.ref.ac.uk. Retrieved 29 May 2023.
  10. ↑ Gibani, MM; Toumazou, C; Sohbati, M; Sahoo, R; Karvela, M; Hon, TK; De Mateo, S; Burdett, A; Leung, KYF; Barnett, J; Orbeladze, A; Luan, S; Pournias, S; Sun, J; Flower, B; Bedzo-Nutakor, J; Amran, M; Quinlan, R; Skolimowska, K; Herrera, C; Rowan, A; Badhan, A; Klaber, R; Davies, G; Muir, D; Randell, P; Crook, D; Taylor, GP; Barclay, W; Mughal, N; Moore, LSP; Jeffery, K; Cooke, GS (November 2020). "Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study". The Lancet. Microbe. 1 (7): e300–e307. doi:10.1016/S2666-5247(20)30121-X. hdl: 10044/1/82918 . PMC   7498257 . PMID   32964211.
  11. ↑ Boseley, Sarah (2020-09-17). "New UK Covid test is effective but won't impact numbers as hoped". The Guardian. ISSN   0261-3077 . Retrieved 2023-08-14.
  12. ↑ "Initiative to increase access to expensive hepatitis drugs in poorer countries". NIHR Imperial Biomedical Research Centre. 31 July 2019. Retrieved 2023-08-14.
  13. ↑ "BBC World Service - World Update, New 'Trojan horse' antibiotic seems promising". BBC. Retrieved 5 March 2019.
  14. ↑ "Four Non-Executive Directors appointed to the Medicines and Healthcare products Regulatory Agency Board". gov.uk. Retrieved 30 October 2021.
  15. ↑ "Dr Graham Cooke". Imperial College Healthcare NHS Trust. Retrieved 2023-08-14.
  16. ↑ "Outstanding biomedical and health researchers elected to Academy of Medical Sciences Fellowship". Academy of Medical Sciences. Retrieved 14 July 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.